Veterinary Medicines

Depomycine, suspensie voor injectie

Authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
Depomycine, suspensie voor injectie
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
  • Pig
  • Pig (piglet)
  • Cattle (calf)
  • Sheep
  • Sheep (lamb)
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        56
        day
    • Pig
      • Meat and offal
        49
        day
    • Pig (piglet)
      • Meat and offal
        49
        day
    • Cattle (calf)
      • Meat and offal
        56
        day
    • Sheep
      • Meat and offal
        56
        day
    • Sheep (lamb)
      • Meat and offal
        56
        day
  • Subcutaneous use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        56
        day
    • Pig
      • Meat and offal
        49
        day
    • Pig (piglet)
      • Meat and offal
        49
        day
    • Cattle (calf)
      • Meat and offal
        56
        day
    • Sheep
      • Meat and offal
        56
        day
    • Sheep (lamb)
      • Meat and offal
        56
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 4264
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/02/2022
Download